经皮肾镜与软性输尿管镜治疗肾结石的应用及效果对照评定

Application and Effect of Percutaneous Nephroscope and Soft Ureteroscope in the Treatment of Renal Calculi

目的该课题旨在探讨肾结石患者应用经皮肾镜(PCNL)与软性输尿管镜(FURS)治疗的临床效果。方法根据治疗方式对112例该院2013年2月—2017年6月期间收治的肾结石患者进行分组。其中,FURS组56例患者采用软性输尿管镜手术治疗,PCNL组56例采用经皮肾镜手术治疗,对比两组清石率、并发症发生率与临床指标。结果FURS组肾结石患者清石率71.43%低于PCNL组的94.64%,并发症发生率3.57%低于PCNL组的23.21%,住院时间(8.54±0.34)d与住院费用(2.36±0.31)万元少于PCNL组的(11.33±0.84)d与(3.24±0.32)万元,手术时间(63.23±15.26)min长于PCNL组的(56.64±13.62)min,差异有统计学意义(P<0.05)。结论肾结石患者可通过PCNL与FURS治疗取得良好的疗效,FURS可显著减少其住院费用与住院时间并降低其并发症发生率,PCNL可显著提高其清石率并减少其手术时间,建议临床合理应用。

Objective This paper tries to explore the clinical effect of patients with renal calculus by using percutaneous nephroscope（PCNL） and soft ureteroscope（FURS）. Methods 112 patients with renal calculi received from February 2013 to June 2017 were divided into two groups according to different treatment methods. 56 patients in FURS group were treated with soft ureteroscopy, and 56 cases of PCNL group were treated with percutaneous nephroscope surgery, the clear stone rate, complication rate and clinical index of two groups were compared. Results The clear stone rate of the FURS group was 71.43%, lower than that of PCNL group of 94.64%, incidence of complications was 3.57%, lower than 23.21% of the PCNL group, length of hospital stay was（8.54±0.34）d and hospitalization expense was（2.36±0.31）ten thousand yuan, less than those of the PCNL group of（11.33 ±0.84）d and（3.24±0.32）ten thousand yuan, the operation time was（63.23 ±15.26）min,longer than the PCNL group of（56.64±13.62） min, with statistically significant difference（P〈0.05）. Conclusion PCNL and FURS treatment for renal calculi patients are remarkable. FURS treatment can significantly reduce the hospitalization costs and reduce the incidence of complications and hospitalization time, and PCNL can significantly increase the clear stone rate and reduce the operation time, so it is worth clinical reasonable application.